IPO registrations (S-1, F-1) · Registrants
Inotiv, Inc.
- SEC CIK
- 720154 · filings on EDGAR ↗
- Former names
- BIOANALYTICAL SYSTEMS INC (1997–2021)
- Registration
- Form S-1, first filed 1997-09-26, last 2021-12-23; 3 initial registrations, 6 amendments
- Outcome
- Final prospectus filed 1997-11-25; declared effective 2011-05-05; withdrawal requested 2022-07-20
- Industry (SIC)
- Services-Commercial Physical & Biological Research 8731
- Incorporated in
- IN
- Business address
- 2701 KENT AVE, West Lafayette, IN 47906-1382
- EIN
- 35-1345024
- EDGAR entity type
- operating
- Insiders and CEO pay
- Inotiv, Inc. on the corporate pages
Offering terms
- Final price
- $8.00 per share (424B1 filed 1997-11-25, an initial public offering)
- Shares sold
- 1,250,000
- Gross proceeds
- $10,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol BASI
- Lead underwriters
- The Ohio Company (545,000 shares)
- Syndicate
- EVEREN Securities, Inc (20,000); David A. Noyes & Co (20,000); First of Michigan Corporation (20,000); Hanifen, Imhoff Inc (20,000); Janney Montgomery Scott (20,000); NatCity Investments, Inc (20,000); Pennsylvania Merchant Group, Ltd (20,000); Stifel (20,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: INOTIV, INC Fuzzy (name and state)
- Business registration: INOTIV, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: INOTIV, INC. EXACT (EIN (EXACT))
- Federal award recipient: INOTIV, INC Fuzzy (name and state)
- Form D issuer: Inotiv, Inc. EXACT (CIK (EXACT))
- Lobbying client: INOTIV, INC. Fuzzy (name and state)
- SEC filer: BIOANALYTICAL SYSTEMS INC EXACT (CIK (EXACT))
- Person page: David L Omachinski Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: David W Crabb Md Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: R Matthew Neff Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 18
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1997-09-26 | S-1 | S-1 (registration) | BIOANALYTICAL SYSTEMS INC | 0000950124-97-004913 ↗ |
| 1997-11-10 | S-1/A | S-1/A (amendment) | BIOANALYTICAL SYSTEMS INC | 0000950124-97-005752 ↗ |
| 1997-11-24 | S-1/A | S-1/A (amendment) | BIOANALYTICAL SYSTEMS INC | 0000950124-97-006177 ↗ |
| 1997-11-24 | S-1/A | S-1/A (amendment) | BIOANALYTICAL SYSTEMS INC | 0000950124-97-006197 ↗ |
| 1997-11-25 | 424B1 | 424B1 (final prospectus) | BIOANALYTICAL SYSTEMS INC | 0000950124-97-006219 ↗ |
| 2011-02-28 | S-1 | S-1 (registration) | BIOANALYTICAL SYSTEMS INC | 0001144204-11-011550 ↗ |
| 2011-03-14 | S-1/A | S-1/A (amendment) | BIOANALYTICAL SYSTEMS INC | 0001144204-11-014564 ↗ |
| 2011-04-20 | S-1/A | S-1/A (amendment) | BIOANALYTICAL SYSTEMS INC | 0001144204-11-023270 ↗ |
| 2011-05-02 | S-1/A | S-1/A (amendment) | BIOANALYTICAL SYSTEMS INC | 0001144204-11-025256 ↗ |
| 2011-05-05 | EFFECT | EFFECT (declared effective) | BIOANALYTICAL SYSTEMS INC | 9999999995-11-001411 ↗ |
| 2011-05-06 | S-1MEF | S-1MEF (added securities) | BIOANALYTICAL SYSTEMS INC | 0001144204-11-026644 ↗ |
| 2011-05-06 | 424B4 | 424B4 (final prospectus) | BIOANALYTICAL SYSTEMS INC | 0001144204-11-026775 ↗ |
| 2014-03-07 | EFFECT | EFFECT (declared effective) | BIOANALYTICAL SYSTEMS INC | 9999999995-14-000612 ↗ |
| 2015-06-10 | EFFECT | EFFECT (declared effective) | BIOANALYTICAL SYSTEMS INC | 9999999995-15-001569 ↗ |
| 2021-03-01 | EFFECT | EFFECT (declared effective) | BIOANALYTICAL SYSTEMS INC | 9999999995-21-000788 ↗ |
| 2021-12-23 | S-1 | S-1 (registration) | Inotiv, Inc. | 0001104659-21-153236 ↗ |
| 2022-07-20 | RW | RW (withdrawal request) | Inotiv, Inc. | 0001104659-22-081011 ↗ |
| 2022-08-31 | EFFECT | EFFECT (declared effective) | Inotiv, Inc. | 9999999995-22-002565 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1997-11-24 | S-1/A | registration statement | $8.00 | 1,250,000 | $10,000,000 | Nasdaq BASI | 0 | from the submission text; price sentence, shares headline, proceeds computed | document ↗ | |
| 1997-11-24 | S-1/A | registration statement | - | - | 0 | from the submission text; no terms found | document ↗ | |||
| 1997-11-25 | 424B1 | final prospectus | $8.00 | 1,250,000 | $10,000,000 | Nasdaq BASI | 9 | from the submission text; price sentence, shares headline, proceeds computed, underwriting table 9 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| BRUNTLETT CRAIG S | Officer | Senior V P International Sales; Senior V P, Sales Development; Senior VP, Sales Development; Sr. Vice Pres. International | 10 | 2006–2010 | |
| SHOUP RONALD E | Director,Officer; Officer | Chief Operating Officer; Chief Scientific Officer | 5 | 2006–2007 | |
| BAITINGER WILLIAM E | Director | 4 | 2006–2008 | ||
| Shepperd Richard M | Director,Officer; Officer | Interim President & CEO; President & CEO; President & Chief Exec. Off. | 4 | 2006–2008 | |
| Boulet Larry Steven | Director | 5 | 2007–2012 | ||
| CHAIT EDWARD | Officer | Chief Business Officer | 1 | 2007 | |
| COX MICHAEL R | Officer | VP Finance & Administration | 3 | 2007–2010 | |
| REEVES-KERNER LINA L | Officer | V.P. Human Resources | 3 | 2007–2010 | |
| Cordova Emilio | Officer | V.P. of Business Development | 2 | 2007 | |
| KISSINGER CANDICE B | TenPercentOwner | 6 | 2008–2018 | ||
| KISSINGER PETER | TenPercentOwner | 6 | 2008–2018 | ||
| DANIELS LESLIE B | Director | 2 | 2008–2010 | ||
| BREWER JON | Officer | VP Sales/Marketing | 2 | 2008 | |
| Chilton Anthony S | Director,Officer; Officer | CEO and President; COO, Scientific Services; COO, Scientific Studies | 6 | 2008–2012 | |
| OMACHINSKI DAVID L | Director | 4 | 2009–2012 | person page Fuzzy | |
| Landis John B. | Director | 5 | 2009–2012 | ||
| Sullivan A. Charlene | Director | 3 | 2010–2012 | ||
| CRABB DAVID W | Director | 2 | 2010–2012 | person page Fuzzy | |
| Hodges Kathleen | Officer | Vice President of Quality | 2 | 2010 | |
| Hidalgo Alberto F Jr | Officer | VP, Bus. Development & Mrkting | 2 | 2010 | |
| Costa Brava Partnership III LP | TenPercentOwner | 1 | 2011 | ||
| HAMOT SETH W | TenPercentOwner | 1 | 2011 | ||
| Roark, Rearden & Hamot LLC | TenPercentOwner | 1 | 2011 | ||
| Devine John P | Officer | VP--Non-Clinical Services; VP--Toxicology | 5 | 2011–2014 | |
| Payne Lori | Officer | VP Bioanalytical Services; VP-Bioanalytical Services | 3 | 2012–2013 | |
| Lemke Jacqueline M | Director,Officer; Officer | CFO & Vice President--Finance; Intrm Pres & CEO, CFO & VP Fin; President and CEO | 8 | 2012–2016 | |
| Johnson Richard Allen | Director | 11 | 2012–2023 | ||
| Downing Philip A | Officer | Sen. Dir., Preclinical Srvcs.; Sr. VP, Preclinical Srvcs.; VP, Preclinical Srvcs. | 15 | 2013–2022 | |
| Rohde-Johnson Candace A | Officer | Director, Instruments | 1 | 2013 | |
| Merrill R. Osheroff | Director | 1 | 2014 | ||
| Bourdage James Sevall | Officer | VP, Bioanalytical Services | 3 | 2014 | |
| Potrzebowski Jeffrey | Officer | VP, Finance & CFO | 2 | 2014 | |
| Dougherty Connie Leigh | Officer | VP, Business Development | 6 | 2014–2016 | |
| Perrow Wendy | Director | 4 | 2015–2019 | ||
| Blumhoff Jill | Officer | VP, Finance & CFO | 8 | 2016–2019 | |
| Davis Gregory Cole | Director | 10 | 2017–2023 | ||
| Neff R Matthew | Director | 31 | 2017–2026 | person page Fuzzy | |
| Baim Michael | Officer | VP Bioanalytical Services | 5 | 2018–2020 | |
| Sagartz John E | Director,Officer; Director,TenPercentOwner; Officer | Chief Strategy Officer | 21 | 2018–2026 | |
| Sagartz Kimberly L | TenPercentOwner | 2 | 2018–2019 | ||
| SW Chrysalis, LLC | TenPercentOwner | 2 | 2018–2019 | ||
| Leasure Robert Jr. | Director,Officer | President and CEO; PRESIDENT AND CEO | 31 | 2019–2026 | |
| Oakley Daniel Thomas | Officer | Chief Operating Officer | 12 | 2019 | |
| Flynn Joseph Earl | Officer | Chief Commercial Officer | 4 | 2019–2021 | |
| Pitchford William D | Officer | Chief HR Officer; Chief Human Resources Officer | 12 | 2019–2022 | |
| Taylor Beth | Officer | Chief Financial Officer; VP- Finance & CFO | 22 | 2020–2026 | |
| Beattie John Gregory | Officer | Chief Operating Officer | 18 | 2021–2026 | |
| Bibi Mark L | Officer | General Counsel and Secretary | 3 | 2021–2022 | |
| Brown Nigel | Director | 9 | 2021–2026 | ||
| Cragg Scott | Director; Director,TenPercentOwner | 6 | 2021–2022 | ||
| Garrett Michael | Officer | Chief Commercial Officer | 7 | 2021–2023 | |
| Hardy Adrian | Officer | Chief Commercial Officer; Executive VP | 9 | 2021–2026 | |
| Harkness James | Officer | Chief Operating Officer, RMS | 4 | 2021–2022 | |
| BAKER ANDREW H | TenPercentOwner | 3 | 2021–2022 | ||
| Jermyn Street Associates LLC | TenPercentOwner | 3 | 2021–2022 | ||
| MOLLER CLAUS J | TenPercentOwner | 2 | 2021–2022 | ||
| P2 Capital Fund IV, L.P. | Other | 2 | 2021–2022 | ||
| P2 Capital Master Fund I, L.P. | Other | 2 | 2021–2022 | ||
| P2 Capital Partners, LLC | TenPercentOwner | 2 | 2021–2022 | ||
| Savanna Holdings, LLC | TenPercentOwner | 2 | 2021–2022 | ||
| Beraldi Fernanda | Officer | Former Gen'l Counsel & Sec'y; General Counsel & Secretary | 5 | 2022–2024 | |
| Freeman Jeffrey Brennan | Officer | VP-Finance & Corp. Controller | 11 | 2022–2026 | |
| Krupp Jeffrey Arthur | Officer | Chief Human Resources Officer | 7 | 2023–2025 | |
| Landman David | Director | 7 | 2023–2026 | ||
| Coelho Mary Theresa | Director | 6 | 2023–2026 | ||
| Castetter Andrea | Officer | EVP, GC, Sec'y & CCO; EVP, General Counsel & Sec'y; SVP, Gen. Counsel & Secretary | 9 | 2023–2026 | |
| Harrington Michael J | Director | 5 | 2024–2026 | ||
| DAVIS EUGENE I | Director | 1 | 2026 | ||
| Young John T. Jr. | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2021-11-16 | Inotiv, Inc. | Other Health Care | $275,000,000 | $275,000,000 | 71 | 1 |
| 2021-10-19 | Inotiv, Inc. | Other Health Care | $5,000,000 | $5,000,000 | 39 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | INOTIV, INC. | IN | Form 5500 (employee benefit plans) | EIN (EXACT) |
| Form D issuer | Inotiv, Inc. | IN | Form D private offerings | CIK (EXACT) |
| Nonprofit | SOCIETY FOR ELECTROANALYTICAL CHEMISTRY INC | IN | Nonprofits (IRS Form 990) | same street address and ZIP code, 2701 KENT AVE 47906 (FUZZY: a shared address, not proof of a shared organization) |
| SEC filer | Inotiv, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | INOTIV, INC | State business registries | name and state | |
| Business registration | INOTIV, INC. | State business registries | name and state | |
| Form 5500 plan sponsor | INOTIV, INC. | EIN (EXACT) | ||
| Federal award recipient | INOTIV, INC | Federal spending (USAspending) | name and state | |
| Lobbying client | INOTIV, INC. | Federal lobbying (LDA) | name and state | |
| Person page | David L Omachinski | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | David W Crabb Md | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | R Matthew Neff | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Services-Commercial Physical & Biological Research, IN first:
- COMBICHEM INC CA
- AURORA BIOSCIENCES CORP CA
- DGI RESOLUTION INC K6
- PRA INTERNATIONAL INC VA
- QUEST DIAGNOSTICS INVESTMENTS INC NJ
- SIGNAL PHARMACEUTICALS INC CA
- CURAGEN CORP MA
- DELTAGEN INC CA
- BIORELIANCE CORP MD
- KENDLE INTERNATIONAL INC OH
In other datasets, the same topic (Medical research) in IN:
- Form D issuer: 34 Lives, PBC (Form D private offerings)
- Nonprofit: ADAMS BRAIN CHARITY (Nonprofits (IRS Form 990))
Interests: Services-Commercial Physical & Biological Research · Medical research